WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013121334) AGENTS FOR TREATING NEURODEGENERATIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/121334    International Application No.:    PCT/IB2013/051072
Publication Date: 22.08.2013 International Filing Date: 08.02.2013
IPC:
C07D 229/02 (2006.01), C07D 231/54 (2006.01), C07D 403/06 (2006.01), A61K 31/396 (2006.01), A61P 25/00 (2006.01)
Applicants: CRO CONSULTING LIMITED [GB/--]; Trident Chambers P.O. Box 146 Road Town Tortola (VG).
MAKHOVA, Nina, N. [RU/RU]; (RU).
PETUKHOVA, Vera, Y. [RU/RU]; (RU).
SHEVTSOV, Alexander, V. [RU/RU]; (RU).
NOVAKOVSKIY, Vladimir, V. [RU/RU]; (RU).
KUZNETSOV, Vladimir, Vladimirovich [RU/RU]; (RU)
Inventors: MAKHOVA, Nina, N.; (RU).
PETUKHOVA, Vera, Y.; (RU).
SHEVTSOV, Alexander, V.; (RU).
NOVAKOVSKIY, Vladimir, V.; (RU).
KUZNETSOV, Vladimir, Vladimirovich; (RU)
Priority Data:
61/600,037 17.02.2012 US
Title (EN) AGENTS FOR TREATING NEURODEGENERATIVE DISORDERS
(FR) AGENTS POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
Abstract: front page image
(EN)The present invention relates to compounds of formula I, use of these compounds to treat mental and neurological disorders, especially depressions and psychoses of different etiology and methods for their preparation. The compounds provided for the treatment of mental and neurological disorders are presented by a general formula I wherein R, R', R", R'" are as defined in specification or pharmaceutically acceptable salts thereof, solvates thereof such as hydrates, and pharmaceutical compositions containing such compounds.
(FR)La présente invention concerne des composés de la formule I, l'utilisation de ces composés pour traiter des maladies mentales et neurologiques, en particulier des dépressions et des psychoses d'étiologie différente et leurs procédés de préparation. Les composés fournis pour le traitement de maladies mentales et neurologiques sont présentés par une formule générale I, dans laquelle R, R', R'', R''' sont tels que définis dans une spécification ou des sels pharmaceutiquement acceptables de celux-ci, des solvates de ceux-ci tels que des hydrates, et des compositions pharmaceutiques contenant de tels composés.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)